Global Choroidal Neovascularization Market Research Report 2023(Status and Outlook)
Report Overview
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
Bosson Research’s latest report provides a deep insight into the global Choroidal Neovascularization market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Choroidal Neovascularization Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Choroidal Neovascularization market in any manner.
Global Choroidal Neovascularization Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Market Segmentation (by Type)
Intravenous
Intravitreal
Market Segmentation (by Application)
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Choroidal Neovascularization Market
Overview of the regional outlook of the Choroidal Neovascularization Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Choroidal Neovascularization Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Choroidal Neovascularization
1.2 Key Market Segments
1.2.1 Choroidal Neovascularization Segment by Type
1.2.2 Choroidal Neovascularization Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHOROIDAL NEOVASCULARIZATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Choroidal Neovascularization Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Choroidal Neovascularization Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHOROIDAL NEOVASCULARIZATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Choroidal Neovascularization Sales by Manufacturers (2018-2023)
3.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2018-2023)
3.3 Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Choroidal Neovascularization Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Choroidal Neovascularization Sales Sites, Area Served, Product Type
3.6 Choroidal Neovascularization Market Competitive Situation and Trends
3.6.1 Choroidal Neovascularization Market Concentration Rate
3.6.2 Global 5 and 10 Largest Choroidal Neovascularization Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CHOROIDAL NEOVASCULARIZATION INDUSTRY CHAIN ANALYSIS
4.1 Choroidal Neovascularization Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHOROIDAL NEOVASCULARIZATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Choroidal Neovascularization Sales Market Share by Type (2018-2023)
6.3 Global Choroidal Neovascularization Market Size Market Share by Type (2018-2023)
6.4 Global Choroidal Neovascularization Price by Type (2018-2023)
7 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Choroidal Neovascularization Market Sales by Application (2018-2023)
7.3 Global Choroidal Neovascularization Market Size (M USD) by Application (2018-2023)
7.4 Global Choroidal Neovascularization Sales Growth Rate by Application (2018-2023)
8 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY REGION
8.1 Global Choroidal Neovascularization Sales by Region
8.1.1 Global Choroidal Neovascularization Sales by Region
8.1.2 Global Choroidal Neovascularization Sales Market Share by Region
8.2 North America
8.2.1 North America Choroidal Neovascularization Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Choroidal Neovascularization Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Choroidal Neovascularization Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Choroidal Neovascularization Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Choroidal Neovascularization Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Choroidal Neovascularization Basic Information
9.1.2 Pfizer Inc. Choroidal Neovascularization Product Overview
9.1.3 Pfizer Inc. Choroidal Neovascularization Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Choroidal Neovascularization SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Basic Information
9.2.2 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
9.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd. Business Overview
9.2.5 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Choroidal Neovascularization Basic Information
9.3.2 Novartis AG Choroidal Neovascularization Product Overview
9.3.3 Novartis AG Choroidal Neovascularization Product Market Performance
9.3.4 Novartis AG Business Overview
9.3.5 Novartis AG Choroidal Neovascularization SWOT Analysis
9.3.6 Novartis AG Recent Developments
9.4 Regeneron Pharmaceuticals Inc.
9.4.1 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Basic Information
9.4.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
9.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Market Performance
9.4.4 Regeneron Pharmaceuticals Inc. Business Overview
9.4.5 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization SWOT Analysis
9.4.6 Regeneron Pharmaceuticals Inc. Recent Developments
9.5 Bayer AG
9.5.1 Bayer AG Choroidal Neovascularization Basic Information
9.5.2 Bayer AG Choroidal Neovascularization Product Overview
9.5.3 Bayer AG Choroidal Neovascularization Product Market Performance
9.5.4 Bayer AG Business Overview
9.5.5 Bayer AG Choroidal Neovascularization SWOT Analysis
9.5.6 Bayer AG Recent Developments
9.6 QLT Inc.
9.6.1 QLT Inc. Choroidal Neovascularization Basic Information
9.6.2 QLT Inc. Choroidal Neovascularization Product Overview
9.6.3 QLT Inc. Choroidal Neovascularization Product Market Performance
9.6.4 QLT Inc. Business Overview
9.6.5 QLT Inc. Recent Developments
9.7 Sanwa Kagaku Kenkyusho Co. Ltd.
9.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Basic Information
9.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
9.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Market Performance
9.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
9.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
9.8 Promedior Inc.
9.8.1 Promedior Inc. Choroidal Neovascularization Basic Information
9.8.2 Promedior Inc. Choroidal Neovascularization Product Overview
9.8.3 Promedior Inc. Choroidal Neovascularization Product Market Performance
9.8.4 Promedior Inc. Business Overview
9.8.5 Promedior Inc. Recent Developments
9.9 Bausch Health
9.9.1 Bausch Health Choroidal Neovascularization Basic Information
9.9.2 Bausch Health Choroidal Neovascularization Product Overview
9.9.3 Bausch Health Choroidal Neovascularization Product Market Performance
9.9.4 Bausch Health Business Overview
9.9.5 Bausch Health Recent Developments
9.10 Gilead Sciences Inc
9.10.1 Gilead Sciences Inc Choroidal Neovascularization Basic Information
9.10.2 Gilead Sciences Inc Choroidal Neovascularization Product Overview
9.10.3 Gilead Sciences Inc Choroidal Neovascularization Product Market Performance
9.10.4 Gilead Sciences Inc Business Overview
9.10.5 Gilead Sciences Inc Recent Developments
10 CHOROIDAL NEOVASCULARIZATION MARKET FORECAST BY REGION
10.1 Global Choroidal Neovascularization Market Size Forecast
10.2 Global Choroidal Neovascularization Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Choroidal Neovascularization Market Size Forecast by Country
10.2.3 Asia Pacific Choroidal Neovascularization Market Size Forecast by Region
10.2.4 South America Choroidal Neovascularization Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Choroidal Neovascularization by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Choroidal Neovascularization Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Choroidal Neovascularization by Type (2024-2029)
11.1.2 Global Choroidal Neovascularization Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Choroidal Neovascularization by Type (2024-2029)
11.2 Global Choroidal Neovascularization Market Forecast by Application (2024-2029)
11.2.1 Global Choroidal Neovascularization Sales (K Units) Forecast by Application
11.2.2 Global Choroidal Neovascularization Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Choroidal Neovascularization
1.2 Key Market Segments
1.2.1 Choroidal Neovascularization Segment by Type
1.2.2 Choroidal Neovascularization Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHOROIDAL NEOVASCULARIZATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Choroidal Neovascularization Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Choroidal Neovascularization Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHOROIDAL NEOVASCULARIZATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Choroidal Neovascularization Sales by Manufacturers (2018-2023)
3.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2018-2023)
3.3 Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Choroidal Neovascularization Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Choroidal Neovascularization Sales Sites, Area Served, Product Type
3.6 Choroidal Neovascularization Market Competitive Situation and Trends
3.6.1 Choroidal Neovascularization Market Concentration Rate
3.6.2 Global 5 and 10 Largest Choroidal Neovascularization Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CHOROIDAL NEOVASCULARIZATION INDUSTRY CHAIN ANALYSIS
4.1 Choroidal Neovascularization Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHOROIDAL NEOVASCULARIZATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Choroidal Neovascularization Sales Market Share by Type (2018-2023)
6.3 Global Choroidal Neovascularization Market Size Market Share by Type (2018-2023)
6.4 Global Choroidal Neovascularization Price by Type (2018-2023)
7 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Choroidal Neovascularization Market Sales by Application (2018-2023)
7.3 Global Choroidal Neovascularization Market Size (M USD) by Application (2018-2023)
7.4 Global Choroidal Neovascularization Sales Growth Rate by Application (2018-2023)
8 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY REGION
8.1 Global Choroidal Neovascularization Sales by Region
8.1.1 Global Choroidal Neovascularization Sales by Region
8.1.2 Global Choroidal Neovascularization Sales Market Share by Region
8.2 North America
8.2.1 North America Choroidal Neovascularization Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Choroidal Neovascularization Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Choroidal Neovascularization Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Choroidal Neovascularization Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Choroidal Neovascularization Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Choroidal Neovascularization Basic Information
9.1.2 Pfizer Inc. Choroidal Neovascularization Product Overview
9.1.3 Pfizer Inc. Choroidal Neovascularization Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Choroidal Neovascularization SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Basic Information
9.2.2 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
9.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd. Business Overview
9.2.5 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Choroidal Neovascularization Basic Information
9.3.2 Novartis AG Choroidal Neovascularization Product Overview
9.3.3 Novartis AG Choroidal Neovascularization Product Market Performance
9.3.4 Novartis AG Business Overview
9.3.5 Novartis AG Choroidal Neovascularization SWOT Analysis
9.3.6 Novartis AG Recent Developments
9.4 Regeneron Pharmaceuticals Inc.
9.4.1 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Basic Information
9.4.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
9.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Market Performance
9.4.4 Regeneron Pharmaceuticals Inc. Business Overview
9.4.5 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization SWOT Analysis
9.4.6 Regeneron Pharmaceuticals Inc. Recent Developments
9.5 Bayer AG
9.5.1 Bayer AG Choroidal Neovascularization Basic Information
9.5.2 Bayer AG Choroidal Neovascularization Product Overview
9.5.3 Bayer AG Choroidal Neovascularization Product Market Performance
9.5.4 Bayer AG Business Overview
9.5.5 Bayer AG Choroidal Neovascularization SWOT Analysis
9.5.6 Bayer AG Recent Developments
9.6 QLT Inc.
9.6.1 QLT Inc. Choroidal Neovascularization Basic Information
9.6.2 QLT Inc. Choroidal Neovascularization Product Overview
9.6.3 QLT Inc. Choroidal Neovascularization Product Market Performance
9.6.4 QLT Inc. Business Overview
9.6.5 QLT Inc. Recent Developments
9.7 Sanwa Kagaku Kenkyusho Co. Ltd.
9.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Basic Information
9.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
9.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Market Performance
9.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
9.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
9.8 Promedior Inc.
9.8.1 Promedior Inc. Choroidal Neovascularization Basic Information
9.8.2 Promedior Inc. Choroidal Neovascularization Product Overview
9.8.3 Promedior Inc. Choroidal Neovascularization Product Market Performance
9.8.4 Promedior Inc. Business Overview
9.8.5 Promedior Inc. Recent Developments
9.9 Bausch Health
9.9.1 Bausch Health Choroidal Neovascularization Basic Information
9.9.2 Bausch Health Choroidal Neovascularization Product Overview
9.9.3 Bausch Health Choroidal Neovascularization Product Market Performance
9.9.4 Bausch Health Business Overview
9.9.5 Bausch Health Recent Developments
9.10 Gilead Sciences Inc
9.10.1 Gilead Sciences Inc Choroidal Neovascularization Basic Information
9.10.2 Gilead Sciences Inc Choroidal Neovascularization Product Overview
9.10.3 Gilead Sciences Inc Choroidal Neovascularization Product Market Performance
9.10.4 Gilead Sciences Inc Business Overview
9.10.5 Gilead Sciences Inc Recent Developments
10 CHOROIDAL NEOVASCULARIZATION MARKET FORECAST BY REGION
10.1 Global Choroidal Neovascularization Market Size Forecast
10.2 Global Choroidal Neovascularization Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Choroidal Neovascularization Market Size Forecast by Country
10.2.3 Asia Pacific Choroidal Neovascularization Market Size Forecast by Region
10.2.4 South America Choroidal Neovascularization Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Choroidal Neovascularization by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Choroidal Neovascularization Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Choroidal Neovascularization by Type (2024-2029)
11.1.2 Global Choroidal Neovascularization Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Choroidal Neovascularization by Type (2024-2029)
11.2 Global Choroidal Neovascularization Market Forecast by Application (2024-2029)
11.2.1 Global Choroidal Neovascularization Sales (K Units) Forecast by Application
11.2.2 Global Choroidal Neovascularization Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Choroidal Neovascularization Market Size Comparison by Region (M USD)
Table 5. Global Choroidal Neovascularization Sales (K Units) by Manufacturers (2018-2023)
Table 6. Global Choroidal Neovascularization Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Choroidal Neovascularization Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Choroidal Neovascularization Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2022)
Table 10. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Choroidal Neovascularization Sales Sites and Area Served
Table 12. Manufacturers Choroidal Neovascularization Product Type
Table 13. Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Choroidal Neovascularization
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Choroidal Neovascularization Market Challenges
Table 22. Market Restraints
Table 23. Global Choroidal Neovascularization Sales by Type (K Units)
Table 24. Global Choroidal Neovascularization Market Size by Type (M USD)
Table 25. Global Choroidal Neovascularization Sales (K Units) by Type (2018-2023)
Table 26. Global Choroidal Neovascularization Sales Market Share by Type (2018-2023)
Table 27. Global Choroidal Neovascularization Market Size (M USD) by Type (2018-2023)
Table 28. Global Choroidal Neovascularization Market Size Share by Type (2018-2023)
Table 29. Global Choroidal Neovascularization Price (USD/Unit) by Type (2018-2023)
Table 30. Global Choroidal Neovascularization Sales (K Units) by Application
Table 31. Global Choroidal Neovascularization Market Size by Application
Table 32. Global Choroidal Neovascularization Sales by Application (2018-2023) & (K Units)
Table 33. Global Choroidal Neovascularization Sales Market Share by Application (2018-2023)
Table 34. Global Choroidal Neovascularization Sales by Application (2018-2023) & (M USD)
Table 35. Global Choroidal Neovascularization Market Share by Application (2018-2023)
Table 36. Global Choroidal Neovascularization Sales Growth Rate by Application (2018-2023)
Table 37. Global Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)
Table 38. Global Choroidal Neovascularization Sales Market Share by Region (2018-2023)
Table 39. North America Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)
Table 40. Europe Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)
Table 41. Asia Pacific Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)
Table 42. South America Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)
Table 43. Middle East and Africa Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)
Table 44. Pfizer Inc. Choroidal Neovascularization Basic Information
Table 45. Pfizer Inc. Choroidal Neovascularization Product Overview
Table 46. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Choroidal Neovascularization SWOT Analysis
Table 49. Pfizer Inc. Recent Developments
Table 50. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Basic Information
Table 51. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
Table 52. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 53. F. Hoffmann-La Roche Ltd. Business Overview
Table 54. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization SWOT Analysis
Table 55. F. Hoffmann-La Roche Ltd. Recent Developments
Table 56. Novartis AG Choroidal Neovascularization Basic Information
Table 57. Novartis AG Choroidal Neovascularization Product Overview
Table 58. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Choroidal Neovascularization SWOT Analysis
Table 61. Novartis AG Recent Developments
Table 62. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Basic Information
Table 63. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
Table 64. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Regeneron Pharmaceuticals Inc. Business Overview
Table 66. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization SWOT Analysis
Table 67. Regeneron Pharmaceuticals Inc. Recent Developments
Table 68. Bayer AG Choroidal Neovascularization Basic Information
Table 69. Bayer AG Choroidal Neovascularization Product Overview
Table 70. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 71. Bayer AG Business Overview
Table 72. Bayer AG Choroidal Neovascularization SWOT Analysis
Table 73. Bayer AG Recent Developments
Table 74. QLT Inc. Choroidal Neovascularization Basic Information
Table 75. QLT Inc. Choroidal Neovascularization Product Overview
Table 76. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. QLT Inc. Business Overview
Table 78. QLT Inc. Recent Developments
Table 79. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Basic Information
Table 80. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
Table 81. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
Table 83. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
Table 84. Promedior Inc. Choroidal Neovascularization Basic Information
Table 85. Promedior Inc. Choroidal Neovascularization Product Overview
Table 86. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Promedior Inc. Business Overview
Table 88. Promedior Inc. Recent Developments
Table 89. Bausch Health Choroidal Neovascularization Basic Information
Table 90. Bausch Health Choroidal Neovascularization Product Overview
Table 91. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Bausch Health Business Overview
Table 93. Bausch Health Recent Developments
Table 94. Gilead Sciences Inc Choroidal Neovascularization Basic Information
Table 95. Gilead Sciences Inc Choroidal Neovascularization Product Overview
Table 96. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Gilead Sciences Inc Business Overview
Table 98. Gilead Sciences Inc Recent Developments
Table 99. Global Choroidal Neovascularization Sales Forecast by Region (2024-2029) & (K Units)
Table 100. Global Choroidal Neovascularization Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America Choroidal Neovascularization Sales Forecast by Country (2024-2029) & (K Units)
Table 102. North America Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe Choroidal Neovascularization Sales Forecast by Country (2024-2029) & (K Units)
Table 104. Europe Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific Choroidal Neovascularization Sales Forecast by Region (2024-2029) & (K Units)
Table 106. Asia Pacific Choroidal Neovascularization Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America Choroidal Neovascularization Sales Forecast by Country (2024-2029) & (K Units)
Table 108. South America Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa Choroidal Neovascularization Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 111. Global Choroidal Neovascularization Sales Forecast by Type (2024-2029) & (K Units)
Table 112. Global Choroidal Neovascularization Market Size Forecast by Type (2024-2029) & (M USD)
Table 113. Global Choroidal Neovascularization Price Forecast by Type (2024-2029) & (USD/Unit)
Table 114. Global Choroidal Neovascularization Sales (K Units) Forecast by Application (2024-2029)
Table 115. Global Choroidal Neovascularization Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Choroidal Neovascularization Market Size Comparison by Region (M USD)
Table 5. Global Choroidal Neovascularization Sales (K Units) by Manufacturers (2018-2023)
Table 6. Global Choroidal Neovascularization Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Choroidal Neovascularization Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Choroidal Neovascularization Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2022)
Table 10. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Choroidal Neovascularization Sales Sites and Area Served
Table 12. Manufacturers Choroidal Neovascularization Product Type
Table 13. Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Choroidal Neovascularization
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Choroidal Neovascularization Market Challenges
Table 22. Market Restraints
Table 23. Global Choroidal Neovascularization Sales by Type (K Units)
Table 24. Global Choroidal Neovascularization Market Size by Type (M USD)
Table 25. Global Choroidal Neovascularization Sales (K Units) by Type (2018-2023)
Table 26. Global Choroidal Neovascularization Sales Market Share by Type (2018-2023)
Table 27. Global Choroidal Neovascularization Market Size (M USD) by Type (2018-2023)
Table 28. Global Choroidal Neovascularization Market Size Share by Type (2018-2023)
Table 29. Global Choroidal Neovascularization Price (USD/Unit) by Type (2018-2023)
Table 30. Global Choroidal Neovascularization Sales (K Units) by Application
Table 31. Global Choroidal Neovascularization Market Size by Application
Table 32. Global Choroidal Neovascularization Sales by Application (2018-2023) & (K Units)
Table 33. Global Choroidal Neovascularization Sales Market Share by Application (2018-2023)
Table 34. Global Choroidal Neovascularization Sales by Application (2018-2023) & (M USD)
Table 35. Global Choroidal Neovascularization Market Share by Application (2018-2023)
Table 36. Global Choroidal Neovascularization Sales Growth Rate by Application (2018-2023)
Table 37. Global Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)
Table 38. Global Choroidal Neovascularization Sales Market Share by Region (2018-2023)
Table 39. North America Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)
Table 40. Europe Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)
Table 41. Asia Pacific Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)
Table 42. South America Choroidal Neovascularization Sales by Country (2018-2023) & (K Units)
Table 43. Middle East and Africa Choroidal Neovascularization Sales by Region (2018-2023) & (K Units)
Table 44. Pfizer Inc. Choroidal Neovascularization Basic Information
Table 45. Pfizer Inc. Choroidal Neovascularization Product Overview
Table 46. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Choroidal Neovascularization SWOT Analysis
Table 49. Pfizer Inc. Recent Developments
Table 50. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Basic Information
Table 51. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
Table 52. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 53. F. Hoffmann-La Roche Ltd. Business Overview
Table 54. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization SWOT Analysis
Table 55. F. Hoffmann-La Roche Ltd. Recent Developments
Table 56. Novartis AG Choroidal Neovascularization Basic Information
Table 57. Novartis AG Choroidal Neovascularization Product Overview
Table 58. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Choroidal Neovascularization SWOT Analysis
Table 61. Novartis AG Recent Developments
Table 62. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Basic Information
Table 63. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
Table 64. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Regeneron Pharmaceuticals Inc. Business Overview
Table 66. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization SWOT Analysis
Table 67. Regeneron Pharmaceuticals Inc. Recent Developments
Table 68. Bayer AG Choroidal Neovascularization Basic Information
Table 69. Bayer AG Choroidal Neovascularization Product Overview
Table 70. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 71. Bayer AG Business Overview
Table 72. Bayer AG Choroidal Neovascularization SWOT Analysis
Table 73. Bayer AG Recent Developments
Table 74. QLT Inc. Choroidal Neovascularization Basic Information
Table 75. QLT Inc. Choroidal Neovascularization Product Overview
Table 76. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. QLT Inc. Business Overview
Table 78. QLT Inc. Recent Developments
Table 79. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Basic Information
Table 80. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
Table 81. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
Table 83. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
Table 84. Promedior Inc. Choroidal Neovascularization Basic Information
Table 85. Promedior Inc. Choroidal Neovascularization Product Overview
Table 86. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Promedior Inc. Business Overview
Table 88. Promedior Inc. Recent Developments
Table 89. Bausch Health Choroidal Neovascularization Basic Information
Table 90. Bausch Health Choroidal Neovascularization Product Overview
Table 91. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Bausch Health Business Overview
Table 93. Bausch Health Recent Developments
Table 94. Gilead Sciences Inc Choroidal Neovascularization Basic Information
Table 95. Gilead Sciences Inc Choroidal Neovascularization Product Overview
Table 96. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Gilead Sciences Inc Business Overview
Table 98. Gilead Sciences Inc Recent Developments
Table 99. Global Choroidal Neovascularization Sales Forecast by Region (2024-2029) & (K Units)
Table 100. Global Choroidal Neovascularization Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America Choroidal Neovascularization Sales Forecast by Country (2024-2029) & (K Units)
Table 102. North America Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe Choroidal Neovascularization Sales Forecast by Country (2024-2029) & (K Units)
Table 104. Europe Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific Choroidal Neovascularization Sales Forecast by Region (2024-2029) & (K Units)
Table 106. Asia Pacific Choroidal Neovascularization Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America Choroidal Neovascularization Sales Forecast by Country (2024-2029) & (K Units)
Table 108. South America Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa Choroidal Neovascularization Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa Choroidal Neovascularization Market Size Forecast by Country (2024-2029) & (M USD)
Table 111. Global Choroidal Neovascularization Sales Forecast by Type (2024-2029) & (K Units)
Table 112. Global Choroidal Neovascularization Market Size Forecast by Type (2024-2029) & (M USD)
Table 113. Global Choroidal Neovascularization Price Forecast by Type (2024-2029) & (USD/Unit)
Table 114. Global Choroidal Neovascularization Sales (K Units) Forecast by Application (2024-2029)
Table 115. Global Choroidal Neovascularization Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Choroidal Neovascularization
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Choroidal Neovascularization Market Size (M USD), 2018-2029
Figure 5. Global Choroidal Neovascularization Market Size (M USD) (2018-2029)
Figure 6. Global Choroidal Neovascularization Sales (K Units) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Choroidal Neovascularization Market Size by Country (M USD)
Figure 11. Choroidal Neovascularization Sales Share by Manufacturers in 2022
Figure 12. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2022
Figure 13. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Choroidal Neovascularization Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Choroidal Neovascularization Market Share by Type
Figure 18. Sales Market Share of Choroidal Neovascularization by Type (2018-2023)
Figure 19. Sales Market Share of Choroidal Neovascularization by Type in 2022
Figure 20. Market Size Share of Choroidal Neovascularization by Type (2018-2023)
Figure 21. Market Size Market Share of Choroidal Neovascularization by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Choroidal Neovascularization Market Share by Application
Figure 24. Global Choroidal Neovascularization Sales Market Share by Application (2018-2023)
Figure 25. Global Choroidal Neovascularization Sales Market Share by Application in 2022
Figure 26. Global Choroidal Neovascularization Market Share by Application (2018-2023)
Figure 27. Global Choroidal Neovascularization Market Share by Application in 2022
Figure 28. Global Choroidal Neovascularization Sales Growth Rate by Application (2018-2023)
Figure 29. Global Choroidal Neovascularization Sales Market Share by Region (2018-2023)
Figure 30. North America Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 31. North America Choroidal Neovascularization Sales Market Share by Country in 2022
Figure 32. U.S. Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 33. Canada Choroidal Neovascularization Sales (K Units) and Growth Rate (2018-2023)
Figure 34. Mexico Choroidal Neovascularization Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 36. Europe Choroidal Neovascularization Sales Market Share by Country in 2022
Figure 37. Germany Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 38. France Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 39. U.K. Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 40. Italy Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 41. Russia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 42. Asia Pacific Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Choroidal Neovascularization Sales Market Share by Region in 2022
Figure 44. China Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 45. Japan Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 46. South Korea Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 47. India Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 48. Southeast Asia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 49. South America Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 50. South America Choroidal Neovascularization Sales Market Share by Country in 2022
Figure 51. Brazil Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 52. Argentina Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 53. Columbia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 54. Middle East and Africa Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Choroidal Neovascularization Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 57. UAE Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 58. Egypt Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 59. Nigeria Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 60. South Africa Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 61. Global Choroidal Neovascularization Sales Forecast by Volume (2018-2029) & (K Units)
Figure 62. Global Choroidal Neovascularization Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Choroidal Neovascularization Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Choroidal Neovascularization Market Share Forecast by Type (2024-2029)
Figure 65. Global Choroidal Neovascularization Sales Forecast by Application (2024-2029)
Figure 66. Global Choroidal Neovascularization Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of Choroidal Neovascularization
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Choroidal Neovascularization Market Size (M USD), 2018-2029
Figure 5. Global Choroidal Neovascularization Market Size (M USD) (2018-2029)
Figure 6. Global Choroidal Neovascularization Sales (K Units) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Choroidal Neovascularization Market Size by Country (M USD)
Figure 11. Choroidal Neovascularization Sales Share by Manufacturers in 2022
Figure 12. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2022
Figure 13. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Choroidal Neovascularization Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Choroidal Neovascularization Market Share by Type
Figure 18. Sales Market Share of Choroidal Neovascularization by Type (2018-2023)
Figure 19. Sales Market Share of Choroidal Neovascularization by Type in 2022
Figure 20. Market Size Share of Choroidal Neovascularization by Type (2018-2023)
Figure 21. Market Size Market Share of Choroidal Neovascularization by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Choroidal Neovascularization Market Share by Application
Figure 24. Global Choroidal Neovascularization Sales Market Share by Application (2018-2023)
Figure 25. Global Choroidal Neovascularization Sales Market Share by Application in 2022
Figure 26. Global Choroidal Neovascularization Market Share by Application (2018-2023)
Figure 27. Global Choroidal Neovascularization Market Share by Application in 2022
Figure 28. Global Choroidal Neovascularization Sales Growth Rate by Application (2018-2023)
Figure 29. Global Choroidal Neovascularization Sales Market Share by Region (2018-2023)
Figure 30. North America Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 31. North America Choroidal Neovascularization Sales Market Share by Country in 2022
Figure 32. U.S. Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 33. Canada Choroidal Neovascularization Sales (K Units) and Growth Rate (2018-2023)
Figure 34. Mexico Choroidal Neovascularization Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 36. Europe Choroidal Neovascularization Sales Market Share by Country in 2022
Figure 37. Germany Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 38. France Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 39. U.K. Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 40. Italy Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 41. Russia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 42. Asia Pacific Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Choroidal Neovascularization Sales Market Share by Region in 2022
Figure 44. China Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 45. Japan Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 46. South Korea Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 47. India Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 48. Southeast Asia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 49. South America Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 50. South America Choroidal Neovascularization Sales Market Share by Country in 2022
Figure 51. Brazil Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 52. Argentina Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 53. Columbia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 54. Middle East and Africa Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Choroidal Neovascularization Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 57. UAE Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 58. Egypt Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 59. Nigeria Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 60. South Africa Choroidal Neovascularization Sales and Growth Rate (2018-2023) & (K Units)
Figure 61. Global Choroidal Neovascularization Sales Forecast by Volume (2018-2029) & (K Units)
Figure 62. Global Choroidal Neovascularization Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Choroidal Neovascularization Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Choroidal Neovascularization Market Share Forecast by Type (2024-2029)
Figure 65. Global Choroidal Neovascularization Sales Forecast by Application (2024-2029)
Figure 66. Global Choroidal Neovascularization Market Share Forecast by Application (2024-2029)
